FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

SUNPHARMA Share Price Discussion

Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Sector: Pharmaceuticals and health care
Find answers to all your questions on live SUNPHARMA message board: Is SUNPHARMA buy or sell? Should I buy SUNPHARMA shares? Why are SUNPHARMA shares falling? Should I invest in SUNPHARMA stock?

You can also check SUNPHARMA share price target recommended by brokerages.
@rajivkumarjha • Reputation: -194,090
robotech trade in SUNPHARMA
321 sf bk

Othr sty
Like
reply
Reply
Recent posts in SUNPHARMA
@newsbot • Reputation: 2,292
Will the Wockhardt move help Dr Reddy's break into the big league?
Analysts say unlike previous attempts, Dr Reddy’s is making more concerted effort to expand in India
Moneycontrol
Like
reply
Reply

BUY
🌞 SUNPHARMA
420 call #9.50_8
SL #4
Trg @20
Like
reply
Reply
@100billionclub • Reputation: 9,731
SUNPHARMA FEB20 FUT

Type
Buy
Instrument
SUNPHARMA FEB20 FUT
Entry Price
₹421.5
Price@Trade
₹421.05
Target Price
₹426
Stop Price
₹417
Valid Till
Feb 14, 2020 3:20 PM
Margin
₹93,063.06 approx for 1250 Qty
Status
Stoploss Hit
Exit Price
₹417
Net P&L
-6.04% Loss
Like
reply
Reply (2)
@databot • Reputation: 1,630

Karvy Stock Broking target on SUNPHARMA
Date: 10-Feb-20 Broker: Karvy Stock Broking Price @ Call: 423.24 Target: 458 Recommendation: HOLD
Like
reply
Reply
@rajivkumarjha • Reputation: -194,090
SUNPHARMA FEB20 410 CE

Type
Buy
Instrument
SUNPHARMA FEB20 410 CE
Entry Price
₹12.95
Price@Trade
₹12.95
Target Price
₹35
Stop Price
₹6
Valid Till
Feb 27, 2020 3:20 PM
Margin
₹16,187.5 approx for 1250 Qty
Status
Exited
Exit Price
₹16.45
Net P&L
27.03% Profit
Like
reply
Reply (1)
@rajivkumarjha • Reputation: -194,090
SUNPHARMA FEB20 410 CE

Type
Buy
Instrument
SUNPHARMA FEB20 410 CE
Entry Price
₹13
Price@Trade
₹13.25
Target Price
₹40
Stop Price
₹8
Valid Till
Feb 27, 2020 3:20 PM
Margin
₹16,250 approx for 1250 Qty
Status
Exited
Exit Price
₹16.45
Net P&L
26.54% Profit
Like
reply
Reply (2)